Reported 2 days ago
Morgan Stanley has started coverage of Centene Corporation (NYSE:CNC) with an Overweight rating and a price target of $70, projecting an 8.8% compound annual growth rate (CAGR) for EPS over the next three years. Analysts highlighted Centene's strong position in the Medicaid market and potential growth opportunities, particularly in ICHRA and D-SNP integration, while also noting the likelihood of ongoing cost reductions and margin improvements.
Source: YAHOO